Guangxi Key Laboratory of Medicinal Resources Protection and Genetic Improvement, National Engineering Research Center for Southwest Endangered Medicinal Resources Development, National Center for TCM Inheritance and Innovation, Guangxi Botanical Garden of Medicinal Plants, Nanning, China.
Department of Ultrasound, Shandong Provincial Hospital Affiliated To Shandong First Medical University, Jinan, China.
Front Endocrinol (Lausanne). 2023 Sep 18;14:1229777. doi: 10.3389/fendo.2023.1229777. eCollection 2023.
Ganshu Nuodan is a liver-protecting dietary supplement composed of () spore powder, (Lour.) Merr. (), Bunge () and (Fisch.) Bunge. (). However, its pharmacodynamic material basis and mechanism of action remain unknown.
A mouse model of acute alcohol liver disease (ALD) induced by intragastric administration of 50% alcohol was used to evaluate the hepatoprotective effect of Ganshu Nuodan. The chemical constituents of Ganshu Nuodan were comprehensively identified by UPLC-QTOF/MS, and then its pharmacodynamic material basis and potential mechanism of action were explored by proteomics and network pharmacology.
Ganshu Nuodan could ameliorate acute ALD, which is mainly manifested in the significant reduction of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum and malondialdehyde (MDA) content in liver and the remarkably increase of glutathione (GSH) content and superoxide dismutase (SOD) activity in liver. Totally 76 chemical constituents were identified from Ganshu Nuodan by UPLC-QTOF/MS, including 21 quinones, 18 flavonoids, 11 organic acids, 7 terpenoids, 5 ketones, 4 sterols, 3 coumarins and 7 others. Three key signaling pathways were identified via proteomics studies, namely Arachidonic acid metabolism, Retinol metabolism, and HIF-1 signaling pathway respectively. Combined with network pharmacology and molecular docking, six key targets were subsequently obtained, including Ephx2, Lta4h, Map2k1, Stat3, Mtor and Dgat1. Finally, these six key targets and their related components were verified by molecular docking, which could explain the material basis of the hepatoprotective effect of Ganshu Nuodan.
Ganshu Nuodan can protect acute alcohol-induced liver injury in mice by inhibiting oxidative stress, lipid accumulation and apoptosis. Our study provides a scientific basis for the hepatoprotective effect of Ganshu Nuodan in acute ALD mice and supports its traditional application.
肝苏诺丹是一种护肝膳食补充剂,由()孢子粉、(Lour.)Merr.()、(Bunge)和(Fisch.)Bunge.()组成。然而,其药效物质基础和作用机制尚不清楚。
采用灌胃 50%乙醇诱导小鼠急性酒精性肝病(ALD)模型,评价肝苏诺丹的护肝作用。采用 UPLC-QTOF/MS 对肝苏诺丹的化学成分进行全面鉴定,通过蛋白质组学和网络药理学探讨其药效物质基础及潜在作用机制。
肝苏诺丹能改善急性 ALD,主要表现为血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)显著降低,肝组织丙二醛(MDA)含量降低,谷胱甘肽(GSH)含量和超氧化物歧化酶(SOD)活性显著升高。采用 UPLC-QTOF/MS 从肝苏诺丹中鉴定出 76 种化学成分,包括 21 种醌类、18 种黄酮类、11 种有机酸类、7 种萜类、5 种酮类、4 种甾体类、3 种香豆素类和 7 种其他类。通过蛋白质组学研究,共鉴定出三条关键信号通路,分别为花生四烯酸代谢、视黄醇代谢和 HIF-1 信号通路。结合网络药理学和分子对接,进一步获得 6 个关键靶点,包括 Ephx2、Lta4h、Map2k1、Stat3、Mtor 和 Dgat1。最后,通过分子对接验证了这 6 个关键靶点及其相关成分,可解释肝苏诺丹护肝作用的物质基础。
肝苏诺丹通过抑制氧化应激、脂质积累和凋亡,对急性酒精诱导的肝损伤有保护作用。本研究为肝苏诺丹在急性 ALD 小鼠中的护肝作用提供了科学依据,支持其在临床上的应用。